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Signalling via NO/cGMP regulates diverse physiological
processes such as smooth muscle relaxation, inhibition of
platelet aggregation and modulation of neurotransmis-
sion. To elevate intracellular cGMP concentrations the sig-
nal molecule nitric oxide (NO) binds to the prosthetic
heme group of the NO-sensitive guanylyl cyclase (GC), a
heterodimeric enzyme composed of one α and one β sub-
unit.
Two different isoforms of the NO-sensitive GC have been
shown to exist in vivo; the α1β1 and the α2β1 heterodimer
revealing undistinguishable enzymatic properties. Investi-
gation of the tissue distribution of both GC isoforms
revealed a major occurrence of the α2β1 isoform in brain,
whereas in all other tissues tested, the α1β1 heterodimer
was the predominating isoform.
In order to study the NO/cGMP signalling and to analyse
the functional significance of the GC isoforms, we have
generated conditional knockout mice, in which the gene
coding for the α1- or the α2-subunit can be deleted using
the Cre/loxP system.
Here we report on the phenotypes of mice with deficiency
of the α1- or the α2-subunit of the NO-sensitive GC in all
tissues.
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